PVLA - Palvella Therapeutics, Inc.

Insider Sale by Goin Kathleen (COO)

1 Month
After Trade
Before Trade

Loading data...

Trade Summary

5 days ago, Goin Kathleen, serving as COO at Palvella Therapeutics, Inc. (PVLA), sold 4,302 shares at $117.99 per share, for a total transaction value of $507,611.00.

This sale represents a 100.00% decrease in Goin Kathleen's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, March 18, 2026 and publicly disclosed via SEC Form 4 filing on Friday, March 20, 2026, 2 days after the trade was made.

Palvella Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.

Goin Kathleen

COO

Kathleen Goin is the Chief Operating Officer at Palvella Therapeutics, Inc. (PVLA), a clinical-stage biopharmaceutical company focused on developing therapies for rare genetic skin diseases.[[1]](https://fintool.com/app/research/companies/PVLA/people/kathleen-goin)[[4]](https://www.sec.gov/Archives/edgar/data/1583648/000143774924037515/pirs20241210_8k.htm)[[6]](https://palvellatx.com/about/) Aged 55 and based in Landenberg, PA, she joined Legacy Palvella in October 2019 as VP of Development Operations, advanced to COO in March 2023, and continued in the role post-merger as PVLA's COO since December 2024.[[1]](https://fintool.com/app/research/companies/PVLA/people/kathleen-goin)[[2]](https://rocketreach.co/kathleen-goin-email_9212163) Goin brings extensive experience in clinical operations, having served as VP of Clinical Operations at Clinical Works (myClin) from February 2017 to October 2019 and at Trevena, Inc. from November 2013 to February 2017.[[1]](https://fintool.com/app/research/companies/PVLA/people/kathleen-goin) She holds an M.S. in Occupational Therapy from Misericordia University and a B.S. in Political Science from Rosemont College.[[1]](https://fintool.com/app/research/companies/PVLA/people/kathleen-goin) As a corporate insider, she has executed 2 transactions in PVLA stock over the past 5 years per SEC Form 4 filings.[[3]](https://www.gurufocus.com/insider/262649/kathleen-goin) Her 2024 compensation included a base salary of $381,440, a 100% corporate performance-based cash bonus of $192,520, and significant equity grants.[[1]](https://fintool.com/app/research/companies/PVLA/people/kathleen-goin)

View full insider profile →

Trade Price

$117.99

Quantity

4,302

Total Value

$507,611.00

Shares Owned

0

Trade Date

Wednesday, March 18, 2026

5 days ago

SEC Filing Date

Friday, March 20, 2026

Filed 2 days after trade

HEALTHCAREBIOTECHNOLOGY

About Palvella Therapeutics, Inc.

Company Overview

No company information available
View news mentioning PVLA

💬 Want Deeper Insight?

Use our AI assistant to ask questions about this trade, the insider, or the company.

Chat with AI

Share this trade

https://insidersignal.ai/trade/4948660

🚀 Track Insider Trades in Real-Time

Create a free account to access our full database of insider trades, AI-powered analysis, price alerts, and discover what corporate executives are buying and selling.

✓ Free forever plan available  •  ✓ No credit card required  •  ✓ Cancel anytime